Literature DB >> 11254678

Cutting edge: differential signaling requirements for activation of assembled cyclin D3-cdk4 complexes in B-1 and B-2 lymphocyte subsets.

D A Tanguay1, T P Colarusso, C Doughty, S Pavlovic-Ewers, T L Rothstein, T C Chiles.   

Abstract

B-1 lymphocytes represent a distinct B cell subset with unusual mitogenic responses. PMA alone promotes proliferation in B-1 cells, but not in splenic B-2 cells. Although cyclin D2-cyclin-dependent kinase 4 (cdk4) complexes mediate early retinoblastoma gene product (pRb) phosphorylation in B-1 cells, the transient nature of their accumulation cannot account for the continued increase in pRb phosphorylation, which is maximal at 24 h. We show herein that PMA promotes the accumulation of functional cyclin D3-cdk4 complexes in B-1 cells following loss of cyclin D2. PMA also induces accumulation of cyclin D3-cdk4 complexes in B-2 cells; however, these complexes do not phosphorylate pRb. Thus, PMA is sufficient to induce synthesis and assembly of cyclin D3-cdk4 complexes in B-1 and B-2 cells; however, PMA triggers cyclin D3-cdk4 activation only in B-1 cells. These results reveal a novel regulatory step that controls activation of cyclin D3-cdk4 complexes whose function segregates differentially in B cell subsets.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254678     DOI: 10.4049/jimmunol.166.7.4273

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Cell cycle control mechanisms in B-1 and B-2 lymphoid subsets.

Authors:  Michael J Piatelli; Debra Tanguay; Thomas L Rothstein; Thomas C Chiles
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

2.  3BP2 deficiency impairs the response of B cells, but not T cells, to antigen receptor ligation.

Authors:  Miguel A de la Fuente; Lalit Kumar; Bao Lu; Raif S Geha
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

3.  Cyclin-dependent kinase inhibitor Cdkn2c regulates B cell homeostasis and function in the NZM2410-derived murine lupus susceptibility locus Sle2c1.

Authors:  Zhiwei Xu; Hari-Hara S K Potula; Anusha Vallurupalli; Daniel Perry; Henry Baker; Byron P Croker; Igor Dozmorov; Laurence Morel
Journal:  J Immunol       Date:  2011-05-04       Impact factor: 5.422

4.  FBXL2 is a ubiquitin E3 ligase subunit that triggers mitotic arrest.

Authors:  Bill B Chen; Jennifer R Glasser; Tiffany A Coon; Rama K Mallampalli
Journal:  Cell Cycle       Date:  2011-10-15       Impact factor: 4.534

5.  B cells in murine cervical lymph nodes are conventional B-2 cells.

Authors:  Seung Geun Yeo; Joong Saeng Cho; Dong Choon Park
Journal:  J Korean Med Sci       Date:  2006-06       Impact factor: 2.153

6.  Adult BM generates CD5+ B1 cells containing abundant N-region additions.

Authors:  Nichol E Holodick; Karen Repetny; Xuemei Zhong; Thomas L Rothstein
Journal:  Eur J Immunol       Date:  2009-09       Impact factor: 5.532

Review 7.  Human B-1 cells take the stage.

Authors:  Thomas L Rothstein; Daniel O Griffin; Nichol E Holodick; Tam D Quach; Hiroaki Kaku
Journal:  Ann N Y Acad Sci       Date:  2013-05       Impact factor: 5.691

8.  F-box protein FBXL2 exerts human lung tumor suppressor-like activity by ubiquitin-mediated degradation of cyclin D3 resulting in cell cycle arrest.

Authors:  B B Chen; J R Glasser; T A Coon; R K Mallampalli
Journal:  Oncogene       Date:  2011-10-24       Impact factor: 9.867

9.  A CD25⁻ positive population of activated B1 cells expresses LIFR and responds to LIF.

Authors:  Joseph R Tumang; Nichol E Holodick; Teresa C Vizconde; Hiroaki Kaku; Rubén Francés; Thomas L Rothstein
Journal:  Front Immunol       Date:  2011-03-21       Impact factor: 7.561

Review 10.  Atypical Response of B-1 Cells to BCR Ligation: A Speculative Model.

Authors:  Nichol E Holodick; Thomas L Rothstein
Journal:  Front Immunol       Date:  2013-12-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.